Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? [Brief Reports]
Conclusions—
The SAMMPRIS results do not provide evidence to support the use of PTAS using the Wingspan stent system compared with medical treatment in any examined subpopulation of patients with symptomatic intracranial stenosis, including those with qualifying event hypoperfusion symptoms.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00576693.
Source: Stroke - Category: Neurology Authors: Lutsep, H. L., Lynn, M. J., Cotsonis, G. A., Derdeyn, C. P., Turan, T. N., Fiorella, D., Janis, L. S., Lane, B. F., Montgomery, J., Chimowitz, M. I., for the SAMMPRIS Investigators Tags: Other Stroke Treatment - Medical, Angioplasty and Stenting Brief Reports Source Type: research
More News: Angioplasty | Clinical Trials | Diabetes | Diabetes Mellitus | Endocrinology | Hypertension | Neurology | Peripheral Angioplasty | Proton Pump Inhibitors PPIs | Smokers | Statistics | Stroke